Healthtracka partners US-based insurtech Fleri, receives investment from Akazi Capital

Healthtracka announces partnership with US-based insurtech startup Fleri Inc. Akazi Capital announces undisclosed amount in Healthtracka.

Healthtracka partners US-based insurtech Fleri, receives investment from Akazi Capital

Healthtracka has partnered with Fleri Inc., a United States-based insurance tech startup enabling immigrants to provide healthcare for their loved ones back home.

In the same breath, Akazi Capital has invested an undisclosed amount in Healthtracka. Akazi Capital is a sector-agnostic crowd-powered impact fund that invests up to $250,000 in early-stage startups owned and run by female entrepreneurs in sub-Saharan Africa.

Ifeoluwa Dare-Johnson (CEO) and Victor Amusan (Head of Product) co-founded Healthtracka in February 2021. Healthtracka is a digital health platform that allows users to book appointment for at-home testing. The health tests offered include COVID-19 PCR test, sexually transmitted disease test, and full body checkup.

Under the partnership agreement, Healthtracka will provide at-home health tests for Fleri's customers as they travel into Africa. According to the statement released by Healthtracka, Fleri's customers would have access to at-home lab tests, doctor's result review, and status update notification.

"The team at Healthtracka has proven their deep experience with delivering lab tests at the comfort of people’s homes", Fleri CEO Sam Baddoo said. "Our partnership with Healthtracka allows us to increase the quality of care delivered to the families of our customers back home while keeping it affordable and accessible".

We are excited to partner with Fleri to bring the lab to the doorsteps of members of their network. We believe that this strategic partnership will also fast trackour expansion into other countries in Africa.

— Healthtracka CEO Ifeoluwa Dare-Johnson

Both Healthtracka and Fleri are part of Techstars Toronto's October 2021 cohort.

Akazi Capital invests undisclosed amount in Healthtracka

The Managing Partner of Akazi Capital, Liebe Jeannot, told Benjamindada.com via that the typical ticket size for Akazi ranges from $25,000 to $100,000. "We don't disclose deal-specific information", she said.

"We couldn't pass up the opportunity to invest in Healthtracka", Akazi said in its statement.

"Ifeoluwa’s mission to decentralize lab testing and put the customer’s healthcare back in their control is truly inspiring. The traction they have shown in just a few short months has been astounding, and we know that Ifeoluwa will continue to impress us all over the next few years. She has built a great team and they are expanding their footprint. They have their eye set on expanding beyond Nigeria, and we are excited about seeing their business become the trusted health platform for lab testing in more African countries".

In an interview with with Techpoint, Healthtracka CEO Ifeoluwa had said there's nothing out of the picture; we can think globally. "If we decide to expand into Canada, Techstars has the resources to ensure that we have all the support that we need". Healthtracka is operational Lagos and Ibadan.

Indeed. Treepz, one of the Nigerian startups who joined Techstars Toronto in March 2021, set up its headquarters in Ontario, Canada, upon completion of the accelerator programme.

"At Akazi, we invest in entrepreneurs that are solving pressing problems and building companies that leave the world a better place. Healthtracka is doing exactly that", the investment firm concluded. "Improving the state of healthcare in Africa relies on early detection of medical conditions and appropriate treatment, and they are playing an important role in facilitating this, and improving the lives of many Nigerians in the process".

Healthtracka has raised an undisclosed amount of money over two rounds from three investors, according to Crunchbase. Expectedly, Techstars Toronto and Techstars are among the investors.

Jeannot said, "We aren't too hung up whether it's called pre-seed, seed, etc. For us, it is more important to be viewed as catalytic capital movers, regardless of what the round is categorized as".